Nominated for Secretary:
Michael C. Rowbotham, MD
Current professional title(s) and affiliation:
Chief Research Officer, Sutter Health, Professor, Anesthesia, UCSF (University of California San Francisco, USA), Attending Neurologist, Pain Management Center, UCSF
A brief description of your work and interests in the pain field:
As a global organization, IASP leadership should represent a diversity of experiences. I have achieved international recognition for mechanism-oriented clinical research and innovative clinical trials that have greatly influenced the current therapy landscape. Many of my publications have been on topics that were ignored for too long: ethics, transparency in clinical trials, and publication bias, for example. I have been an educator and research mentor throughout my career. Finally, my work as a research administrator is highly relevant. As the Chief Research Officer for Sutter Health, the 10th largest health care system in the USA, I see the problems presented by poorly managed chronic pain from the entirely different, and instructive, perspective of a large hospital and clinic system. I also have the opportunity to dive deeply into other fields of research. However, my first love is patient care and I remain a clinician still actively involved in seeing pain patients.
A brief statement of why you are interested in running for the position:
IASP can continue to build on past successes while preparing for the future. I feel I have much to offer in helping IASP remain a vibrant and responsible organization seeking to answer diverse questions such as: How do we solve the ‘opioid epidemic’ without relegating our patients to a life of untreated chronic pain? Can IASP do more to educate compassionate practitioners in the developed and developing world? How can IASP better explain to the public and to those who control funding for health care the importance of pain management and pain research? The clinical trials process is flawed, especially when it comes to new therapies for pain. Can translational pain research move from the era of the 0-10 pain scale to the type of molecular profiling and genomics that has revolutionized cancer care?
Listing of IASP activities including current and prior IASP committees, working groups, or SIG leadership groups on which you have served:
Beginning in 1995, I’ve been of service to IASP almost continuously for over two decades. I’ve served in many roles, the most important of which was as Treasurer from 2012-2016. This was a time of unprecedented financial stress for IASP that required several innovations to improve financial tracking and budgeting. I served one term as Councilor (1999-2005), have served on many IASP committees and task forces, and helped organize the 1999 IASP World Congress. At the journal PAIN, I served as a Section Editor (Reviews) for 5 years, and as an Associate Editor. I continue to serve on the Finance Committee and task forces as requested. Although I’ve been in active service to other organizations, such as the American Academy of Neurology and the American Pain Society, IASP has always been first in my heart. I’ve found serving IASP to be emotionally and intellectually enlightening! I believe deeply in IASP’s mission and its role in the global pain community.